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Abstract  1 
Purpose: It is a widely-accepted premise in the scientific community and by athletes alike, 2 
that adding resistance exercise to a regular regimen of endurance training increases 3 
endurance performance in endurance-trained men. However, critical power (CP), 4 
capillarization, and myofiber size remain unaffected by this addition. Therefore, we tested 5 
whether the superimposition of resistance exercise with whole-body vibration and vascular 6 
occlusion (vibroX) would improve these variables in endurance-trained males relative to 7 
resistance exercise alone. Methods: Twenty-one young, endurance-trained males were 8 
randomly assigned either to a vibroX (n = 11) or resistance (n = 10) training group. Both 9 
groups trained in a progressive mode twice a week for 8 weeks. Pre and post training, 10 
histochemical muscle characteristics, thigh muscle size, endurance and strength parameters 11 
were determined. Results: vibroX increased CP (P = 0.001), overall capillary-to-fiber ratio 12 
(P = 0.001) and thigh lean mass (P < 0.001), while these parameters were unaffected by 13 
resistance training. The gain in CP by vibroX was positively correlated with the gain in 14 
capillarization (R2 = 0.605, P = 0.008), and the gain in thigh lean mass was paralleled by 15 
increases in MyHC-1 and MyHC-2 fiber cross-sectional areas and strength. Maximum 16 
voluntary torque and the finite work capacity above CP (W′) increased significantly only 17 
following resistance training. Conclusions: We achieved a proof of concept by 18 
demonstrating that modification of resistance exercise by superimposing side-alternating 19 
whole-body vibration and sustained vascular occlusion induced further improvements in CP, 20 
capillarization and hypertrophy, all of which were not observed with resistance training 21 
alone.  22 
Key words: concurrent training, hypertrophy, endurance performance, side-alternating 23 
whole-body vibration.  24 
ClinicalTrials.gov Identifier: NCT01672281 25 
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Introduction 1 
Training regimens of endurance athletes typically consist of both long, continuous, low-2 
intensity exercise and shorter high-intensity interval trainings (HIT), which are designed to 3 
improve central (e.g. cardiac output) and peripheral (e.g. arterial-venous oxygen difference) 4 
components (Daussin et al. 2007). Taken together, these adaptations increase several 5 
parameters of aerobic function, such as critical power (CP), maximal O2 consumption 6 
(V̇O2max), gas exchange threshold (GET, “anaerobic threshold”), and exercise efficiency.  7 
 8 
It is widely accepted that adding resistance exercise to a regular regimen of endurance 9 
exercise in trained athletes brings further positive effects on endurance performance, as first 10 
described by Hickson et al. (1988). For the sake of clarity, concurrent endurance and 11 
resistance training (RT) in this context means that endurance athletes perform their regular 12 
weekly endurance training regimen, and add 2-3 sessions of RT per week to their individual 13 
training routine (note that recovery time between resistance exercise sessions ≥48 h). The 14 
exact temporal sequence of endurance and RT sessions usually is unknown. It was first 15 
suggested that the positive effects of resistance exercise on endurance performance are based 16 
on alterations in motor unit recruitment (Hickson et al. 1988). More recently, however, Kubo 17 
et al. (2012) proposed that improvements in neural function and increases in tendon stiffness 18 
might also represent possible explanations. Despite the findings indicating that endurance 19 
performance is improved when regular endurance training is supplemented with resistance 20 
exercise, it appears that CP is not influenced by the addition of resistance exercise to the 21 
regimen (Bishop and Jenkins 1996). In accordance with the first mentioned aspect, experts 22 
agree that it is beneficial for most endurance-trained individuals to supplement their 23 
endurance training routine with resistance exercise, as it promotes substantial benefits for the 24 
individual, e.g. cycling economy (Rønnestad et al. 2011). 25 
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 1 
Despite these benefits, there is at least one issue that should be considered. According to the 2 
interference effect (Hickson 1980), endurance exercise has a negative impact on adaptations 3 
to resistance exercise, especially on gains in lean mass. This mechanism seems to appear only 4 
in young and trained individuals. On a molecular level, it is suggested that 5’ adenosine 5 
monophosphate-activated protein kinase (AMPK) phosphorylates and activates tuberous 6 
sclerosis protein 2 (TSC2), which inhibits the mammalian target of rapamycin complex 1 7 
(mTORC1). The downregulation of the key component in integrating resistance training-8 
activated signaling pathways (mTOR) inhibits the myofibrillar protein synthesis (Atherton et 9 
al. 2005, Inoki et al. 2003). In most cases, the interference effect is even positive for 10 
endurance athletes, because they can improve their endurance performance ability without 11 
gaining weight, which has to be carried for the competition distance. However, there are 12 
cases in which endurance athletes may wish to gain lean mass (e.g. road cyclists want to 13 
improve their time trial performance or cross country skiers want to improve their sprint 14 
performance). The addition of resistance training to their high volume of endurance training 15 
leads mostly not to the desired training effect. In these cases, as a result of the high endurance 16 
stimulus AMPK is upregulated and hence, the myofibrillar protein synthesis is reduced or 17 
inhibited (Inoki et al. 2003). These athletes would profit from a novel training modality that 18 
allows both a gain in lean body mass and an increase in endurance performance. 19 
Furthermore, it is well accepted that −especially in the case of trained endurance athletes− RT 20 
generally neither increases V̇O2max, nor mitochondrial content nor capillarization (Aagaard et 21 
al. 2011, Hickson et al. 1988). To further advance endurance athlete performance there is a 22 
need for new, effective, and time-efficient training stimuli that are capable of providing 23 
endurance performance benefits from resistance exercise, and which will serve to further 24 
increase (otherwise possibly capped) structural and functional endurance-type adaptations, 25 
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which, in turn, affect CP.  1 
 2 
We have recently described a novel training modality termed “vibroX”, which might be able 3 
to accommodate these needs mentioned above (Item et al. 2011, 2013). It simultaneously 4 
combines heavy resistance exercise, side-alternating whole-body vibration, and sustained 5 
vascular occlusion. In untrained females (Item et al. 2011), vibroX elicits a concomitant 6 
increase in muscle fiber cross-sectional area (CSA), overall capillary-to-fiber ratio, thigh lean 7 
mass, and endurance capacity. Additionally, we found that compared to resistance exercise 8 
per se, vibroX acutely activates angiogenic and metabolic gene programs, which are 9 
normally activated after endurance but not resistance exercise in recreationally trained men 10 
(Item et al. 2013). Altogether, these results point to a unique role of vibroX in simultaneously 11 
mediating endurance- and resistance-type adaptations in untrained or resistance-trained 12 
individuals, and thus vibroX has the potential of being considered to be a “total conditioning” 13 
stimulus. Moreover, this unique training regimen has been found to be extremely time 14 
efficient. In our first study, concurrent adaptations were achieved with a muscle contraction 15 
time of approximately 9 min per week for a total of 8 weeks [time commitment per training 16 
session: 12-15 min; (Item et al. 2011)]. Although we have already shown the benefits of 17 
vibroX in young healthy untrained women and young healthy recreationally trained men, a 18 
final proof of concept demonstrating that vibroX also works in trained endurance athletes is 19 
warranted.  20 
 21 
Thus, in this study, we aimed to test whether 8 weeks of vibroX would simultaneously 22 
improve CP, capillarization, and myofiber size in young, trained male endurance athletes 23 
matched for CP at baseline. We chose CP as the functional endpoint of endurance 24 
performance, since this approach is believed to be functionally more valuable than the sole 25 
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measurement of discrete physiological values such as GET and V̇O2max (Jones et al. 2010, 1 
Whipp and Ward 2009) or apparently distinct entities such as “short-term and long-term 2 
endurance capacity”. Another reason for choosing CP as the primary outcome variable was 3 
that supplementation of endurance exercise with classical resistance exercise is not believed 4 
to impact this variable (Bishop and Jenkins 1996). Based on our previous results (Item et al. 5 
2011, 2013) and comprehensive work on the effects of resistance exercise in athletes, ranging 6 
from well-trained to highly-trained athletes levels of skill and performance (Aagaard and 7 
Andersen 2010, Hickson et al. 1988, Rønnestad et al. 2012), we hypothesized that only 8 
vibroX would increase CP, overall capillary-to-fiber ratio, myofiber CSAs and thigh lean 9 
mass simultaneously.  10 
 11 
Methods 12 
Participants 13 
Twenty-six endurance-trained males volunteered to participate in this study. The participants 14 
were recruited from different cycling, triathlon and academic sport clubs. Two participants 15 
aborted the study because of illness or personal reasons. After the pretests, participants were 16 
assigned pairwise, according to their CP·kg−1 body mass, to a vibroX or RT group. None of 17 
the participants had been involved in structured RT prior to the study, and the participants 18 
had no or little experience in squat exercise. Study participants were all involved in their 19 
early preparation phase of training (pre-season). They were instructed to maintain their 20 
individual training routine relating to training frequency, as well as training intensity, and 21 
were advised not to include new or additional high-intensity exercise during the study period. 22 
Three participants were excluded from the final analysis because they contravened our 23 
instruction not to stop their individual training during the study period. Thus, the resulting 24 
number of participants was n = 11 and n = 10 for the vibroX and RT group, respectively. 25 
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There were no statistical significant differences in physical and performance characteristics 1 
between the vibroX and the RT group before training (Tab. 1). Participants were fully 2 
informed about the purposes, benefits and risks associated with this study and completed a 3 
routine health questionnaire before giving written informed consent to their participation in 4 
this study. This study was approved by the ethics committee of the canton Zurich and was 5 
conducted in accordance with the declaration of Helsinki. 6 
 7 
Experimental procedures 8 
The study consisted of pre- and post-tests for all participants and 8 weeks of either vibroX or 9 
RT (Fig. 1). On the first testing day, a percutaneous muscle biopsy was obtained from the M. 10 
vastus lateralis using a 6-mm Bergström needle (Dixons Surgical Instruments, Essex, UK) as 11 
previously described (Item et al. 2013). On the second testing day, participants completed an 12 
incremental ramp cycle ergometer test to determine peak power (Ppeak) and peak oxygen 13 
uptake (V̇O2peak). On that occasion, seat and handle bar of the cycle ergometer (Ergoselect 14 
200 K, Ergoline, Bitz, Germany) were adjusted. These settings were adopted for all of the 15 
consecutive trials. After a 3 min rest, the ramp test started at 100 W and involved power 16 
increases of 9 W every 18 s (30 W·min−1) until volitional exhaustion. The participants were 17 
free to choose the cadence but the chosen revolutions per min (rpm) had to be maintained 18 
throughout all the following cycling tests. Volitional exhaustion, i.e. task failure, for all 19 
cycling tests was defined as the point in time when participants stopped pedaling or the 20 
cadence fell more than 5 rpm for > 5 s. On the following testing days, constant-load cycle 21 
ergometer tests at 85, 90, 95 and 105% Ppeak [modified from Brickley et al. (2007) by 22 
including a 85% stage] were completed in a randomized order to determine CP (Hill 1993, 23 
Moritani et al. 1981). After a 3 min rest, participants started with a 5-min warm-up at 75 W 24 
(Brickley et al. 2007). The power was then increased immediately to the given power output. 25 
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These endurance capacity tests were conducted until volitional exhaustion as defined above, 1 
whereupon time to exhaustion (tlim) was recorded. CP and the finite work capacity above CP 2 
(Wʹ) were calculated by applying the linear power-time−1 equation (P = Wʹ · t−1 + CP, Hill 3 
1993). The coefficient of determination R2 for CP was 0.98 ± 0.01 and 0.99 ± 0.02 for the 4 
pre- and posttests, respectively. The typical error expressed as a coefficient of variation for 5 
CP determined in our laboratory was 3.8%. The familiarization sessions were composed of 6 
three attempts for knee extension (dynamometry) and three attempts for both 7 
countermovement jumps (CMJ) and squat jumps (SJ). Furthermore, the participants 8 
performed two sets of six repetitions of squatting without additional weight. Particular 9 
attention was paid to exercise anatomy, form and movement speed. 10 
 11 
Equipment and measurements 12 
Cycling tests. During all cycling tests, participants were equipped with a facemask, which 13 
covered their mouth and nose (Hans Rudolph, Shawnee, KS, USA). The facemask was 14 
connected with an anti-bacterial filter (PALL PRO1087, Pall, East Hills, NY, USA) to an 15 
Innocor™ device (Innocor™, Innovision, Odense, Denmark). Pulmonary gas exchange and 16 
ventilation were continuously measured breath by breath throughout all ergometer trials. 17 
V̇O2peak was determined as the highest mean over a 10-s period.  18 
Knee extension, one repetition maximum (1RM) and jumping test. Knee extensor maximal 19 
voluntary torque (MVT) and rate of force development (RFD) were tested using a 20 
commercially available dynamometer (Con-Trex® MJ, Physiomed Elektromedizin, 21 
Schnaittach/Laipersdorf, Germany). After the body of the participants was stabilized with 22 
straps and handles, they performed 3 maximal knee extensions (ω = 3.14 rad·s−1) separated 23 
by 1 min to assess MVT. Subsequently, the lever arm of the dynamometer was fixed at a 24 
knee angle of 110° (full extension = 180°) and the participants were advised to extend their 25 
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leg as fast and as powerful as possible. RFD was calculated for two time intervals: 0-30 and 1 
0-200 ms. Onset of muscle contraction was defined as baseline + 7.5 N·m (Aagaard et al. 2 
2002). Squat 1RM measurement was performed according to Niewiadomski et al. (2008) 3 
over the individual’s maximal range of motion. Briefly, the warm-up protocol entailed 8 4 
repetitions at 50% of estimated 1RM and 3 repetitions at 70% of estimated 1RM with a 3 min 5 
rest interval between sets. Subsequently, starting with the estimated 1RM, maximal attempts 6 
were made to determine 1RM with a 1 min rest interval between attempts (Matuszak et al. 7 
2003). The load was successively increased to the point where participants were not able to 8 
successfully execute a squat. For the determination of jumping power during CMJs and SJs, 9 
three vertical jumps (separated by 30 s of rest) were performed per jumping maneuver on a 10 
Leonardo Mechanograph® force plate (Novotec Medical, Pforzheim, Germany). For the 11 
detection, storage and analysis of data, we used the manufacturer’s software (Leonardo 12 
Mechanography GRFD version 4.4, Novotec, Pforzheim, Germany). CMJs were performed 13 
with freely moving arms, whereas the SJs were performed with the hands resting on the 14 
waist. 15 
Body composition. A densitometer (Lunar iDXA™, GE Healthcare, Madison, WI, USA) was 16 
used for the determination of body composition and thigh lean mass. The delineation in 17 
region of interest for the thigh was done manually using the integrated software (encore, GE 18 
Healthcare, Madison, WI, USA; version 11.40.004) as follows: ROI upper boundary = 19 
horizontal line just below the ischium, ROI lower boundary = horizontal line between femur 20 
and tibia, ROI lateral boundaries = outer leg cuts. 21 
 22 
Muscle biopsy analysis 23 
Tissue sections were cut at 8-!m thickness in a cryostat maintained at −25 °C, and mounted 24 
on Fisherbrand Superfrost/Plus microscope slides (Fisher Scientific, Pittsburgh, PA, USA). 25 
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The serial cryocut cross-sections were stained using the myofibrillar adenosintriphosphatase 1 
(mATPase) method as previously described (Item et al. 2011). At least 350 muscle fibers 2 
were classified according to their myosin heavy chain (MyHC) isoform into MyHC-1, 3 
MyHC-2A and MyHC-2X. For the analysis of oxidative and glycolytic enzyme activities, we 4 
incubated the sections in media containing succinate dehydrogenase (SDH) and glycerol-3-5 
phosphate dehydrogenase (GPDH), respectively. At least 350 muscle fibers were counted for 6 
each of these two staining procedures. As marker for muscle capillaries, the monoclonal 7 
mouse anti-human CD31 endothelial antibody (DAKO, Carpinteria, Canada, 1:600 dilution) 8 
was used. Overall capillary-to-fiber ratio was calculated by dividing the number of CD31-9 
positive cells by the number of muscle fibers. At least 50 muscle fibers were counted for the 10 
analysis of the capillary-to-fiber ratio (McCall et al. 1998, Porter et al. 2002). We used the 11 
NIH Image J Software (version 1.44o, National Institutes of Health, Bethesda, MD, USA) for 12 
all fiber analyses. Fiber CSAs were determined by fully encircling the borders of the 13 
mATPase stained cells with Adobe Photoshop Pro CS6 (Adobe Systems Incorporated, San 14 
Jose, California, USA) of at least 50 fibers per MyHC isoform (McCall et al. 1998). Fiber 15 
circularity was calculated using the formula (4π·CSA)/(perimeter)2 and only fibers with a 16 
circularity higher than 0.7 were considered for analysis (perfect circle = 1.0). Because of the 17 
low number of counted MyHC-2X fibers, CSA data were pooled to the 2 major fiber types 18 
(MyHC-1 and MyHC-2). 19 
 20 
Training regimen 21 
The participants reported twice per week to the laboratory for the supervised training sessions 22 
(Fig. 1). The vibroX training consisted of loaded (Multipower®, Technogym, Gambettola, 23 
Italy) parallel back squat exercise with superimposed whole-body vibration and sustained 24 
vascular occlusion, as described previously (Item et al. 2011, 2013). Briefly, squats were 25 
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performed on a Galileo® vibration plate (Novotec, Pforzheim, Germany) oscillating at 30 Hz 1 
while tourniquet cuffs (0.09 m width, 0.76 m length; VBM, Sulz a.N., Germany) inflated to 2 
200 mmHg (26.7 kPa) were affixed to the inguinal fold region of the thigh. The suprasystolic 3 
pressure employed here was the highest pressure that was tolerated by the participants in this 4 
setting. One duty cycle consisted of squats until volitional exhaustion, 3 min resting with the 5 
pressure of the cuffs maintained, and 1 min resting with cuffs deflated to 100 mmHg (13.3 6 
kPa). RT was conducted analogous to vibroX but without whole-body vibration and vascular 7 
occlusion. The participants in the RT group were given a break of 3 min between exercise 8 
sets [according to the American College of Sports Medicine (2009)]. Load was set to 70% 9 
1RM at the beginning of the training period and was reduced by approximately 10 % for each 10 
of the following sets to induce volitional muscle failure within 60-100 s of exercise. The load 11 
magnitude was adjusted progressively during the training period to maintain time under 12 
tension between 60 and 100 s (Item et al. 2013, Toigo and Boutellier 2006). During the 13 
training period, the participants performed two duty cycles or sets of the respective training 14 
during the first 4 weeks and three cycles or sets for the remaining of the training period. The 15 
technical exercise execution of the squats consisted of a 4 s eccentric action, a smooth 1-2 s 16 
transition phase and a 4 s concentric action. After each training, the participants were given a 17 
protein shake containing 20 g of whey protein (Nutriathletic Muscle Growth Formula, 18 
Scientifics, Schwyz, Switzerland).  19 
 20 
Statistical analysis 21 
Data are presented as mean values ± standard deviations (SD). Normality of data was visually 22 
ascertained by Q-Q-plots. For the detection of significant differences between groups over 23 
time, a univariate general linear model was applied. For this analysis, the differences 24 
post−pre (∆) of each variable was compared between the groups. Significant differences 25 
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within groups from pre to post intervention were displayed by parameter estimates. This 1 
analysis tested the null hypothesis that ∆ parameter was 0. If ∆ parameter had a P-value lower 2 
than the level of significance, the null hypothesis was rejected meaning that ∆ parameter was 3 
significantly different from 0. A linear regression analysis was used to determine which 4 
training-induced improvement best predicted the increase in CP. Pearson correlations were 5 
performed to assess the relationships between the variables. The muscle biopsies of two 6 
participants could not be analyzed for the mATPase, SDH and GPDH stainings as well as the 7 
CSAs due to technical failures. The level of significance was set at P < 0.05. All statistical 8 
analyses were performed using the software SPSS Statistics 20.0 (SPSS, Chicago, IL, USA). 9 
 10 
Results 11 
Starting from a non-significant higher absolute baseline value (Tab. 1), CP increased by 7.9 ± 12 
7.5 W in the vibroX group, while it remained unchanged in the RT group (Fig. 2). Overall 13 
capillary-to-fiber ratio increased by 8.2 ± 6.8% in the vibroX group, while the RT group 14 
showed no change (−1.0 ± 7.2%, P = 0.528), resulting in a significant group x time 15 
interaction (Fig. 3a). The increase in overall capillary-to-fiber ratio was the only predictor for 16 
the change in CP (adjusted R2 = 0.605, P = 0.008) in the vibroX group. Thigh lean mass 17 
increased by 3.1 ± 1.7% in the vibroX group, whereas a slight, non-significant increase was 18 
observed in the RT group (+1.2 ± 2.0%, P = 0.074; Fig. 3b), yielding a significant group x 19 
time interaction. MyHC-1 and MyHC-2 CSA’s were increased by 24.7 ± 19.9% and 22.2 ± 20 
16.5%, respectively, in the vibroX group, but did not significantly change in the RT group 21 
(+3.6 ± 28.2%, P = 0.643 and +14.9 ± 29.1%, P = 0.119 for MyHC-1 and MyHC-2 CSA, 22 
respectively; Fig. 3c, 3d), with no differences between the groups. There was a correlation 23 
between the increase in overall capillary-to-fiber ratio and the gain in thigh lean mass in the 24 
vibroX group (R2 = 0.301, P = 0.010; results not shown). Furthermore, the change in MyHC-25 
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1 CSA correlated with the change in thigh lean mass in the vibroX group (R2 = 0.631, P = 1 
0.006; results not shown) but not the RT group. MyHC-2A fiber proportion increased in the 2 
vibroX group, and also tended to increase in the RT group (Tab. 2). MyHC-1 fiber and 3 
MyHC-2X fiber proportions did not significantly change from pre- to post-training in both 4 
groups. There were no effects of the two training interventions on GPDH and SDH activity 5 
(Tab. 2).  6 
 7 
Ppeak increased by 5.9 ± 6.1% in the vibroX group, while there was a non-significant increase 8 
of 2.7 ± 5.9% in the RT group (pre vs. post: vibroX: 383.9 ± 45.8 vs. 405.2 ± 41.9 W; 9 
resistance: 379.9 ± 44.0 vs. 389.8 ± 47.4 W). V̇O2peak (pre vs. post: vibroX: 4.58 ± 0.54 vs. 10 
4.63 ± 0.59 l·min−1, P = 0.136; resistance: 4.16 ± 0.46 vs. 4.22 ± 0.45 l·min−1, P = 0.162) and 11 
relative V̇O2peak (pre vs. post: vibroX: 59.0 ± 6.2 vs. 58.9 ± 6.2 ml·min−1·kg−1, P = 0.874; 12 
resistance: 55.2 ± 4.2 vs. 55.9 ± 4.5 ml·min−1·kg−1, P = 0.156) were not altered in response to 13 
the two training interventions. No testing group x time interaction was detected for V̇O2peak (P 14 
= 0.983).  15 
 16 
1RM increased in both training groups (vibroX: +22.2 ± 10.6%, resistance: +31.8 ± 13.4%; 17 
Fig. 4a), with a tendency towards a higher increase in the RT group (P = 0.057). MVT 18 
increased in both groups (vibroX: +3.1 ± 8.5%, resistance: +4.9 ± 4.6%) but the increase was 19 
significant in the RT group only (Fig. 4b). SJ relative maximum power remained unchanged 20 
in the vibroX group while it significantly increased in the RT group (+2.0 ± 4.8% vs. +4.7 ± 21 
5.9%, respectively; Fig. 4c). CMJ relative maximum power significantly increased in the 22 
vibroX training group by 5.0 ± 8.3%, while the increase did not reach statistical significance 23 
in the RT group (+3.1 ± 3.7%; Fig. 4d). RFD during the first 30 ms remained unaffected by 24 
both training interventions (P = 0.867 and P = 0.091 for the vibroX and RT group, 25 
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respectively; Fig. 4e). RFD during the first 200 ms remained constant for vibroX (+3.0 ± 1 
6.8%, P = 0.563) but increased by 14.0 ± 19.5% in response to RT (Fig. 4f). No significant 2 
group differences were found for all these variables. W′ was not significantly elevated from 3 
pre to post vibroX (+5.1 ± 9.6%; pre vs. post: 17.8 ± 4.2 vs. 18.5 ± 3.7 kJ) while it increased 4 
by 10.5 ± 14.9% (pre vs. post: 16.7 ± 3.8 vs. 18.2 ± 3.5 kJ) in the RT group. No testing group 5 
x time interaction was detected for W′ (P = 0.406). During the first 4 weeks, average time 6 
under tension per training session was 135 ± 18 s and 161 ± 6 s in the vibroX and RT group, 7 
respectively (P < 0.001). In the remaining 4 weeks, average time under tension per training 8 
session was 188 ± 17 s and 218 ± 10 s for the vibroX and RT group (P < 0.001). 9 
 10 
Discussion  11 
This study provides evidence that in trained endurance athletes undergoing regular pre-season 12 
training, the addition of vibroX increased CP, capillary-to-fiber ratio and thigh lean mass. 13 
Conversely, in the RT group, all these parameters remained unaffected by the addition of 14 
conventional RT. The gain in CP was positively correlated with the gain in capillarization, 15 
and the gain in thigh lean mass was paralleled by increases in MyHC-1 and MyHC-2 fiber 16 
CSAs and strength. The present data extend our previous findings (Item et al. 2011, 2013) to 17 
trained endurance athletes and thus establish the final proof of concept that in young healthy 18 
individuals it is possible to modify a resistance exercise stimulus through superimposition of 19 
vibration and sustained vascular occlusion to mediate adaptations otherwise known to occur 20 
with endurance exercise only.  21 !22 
In this study, vibroX but not conventional RT, induced muscle hypertrophy, as shown by the 23 
specific increases in MyHC-1 and MyHC-2 fiber CSAs and thigh lean mass. Our finding that 24 
supplementation of endurance exercise with vibroX promoted muscle hypertrophy is 25 
   15 
intriguing, since in young men, adaptations to RT are usually negatively affected by 1 
concurrent endurance exercise, i.e. simultaneous endurance exercise impairs “strength” and 2 
muscle size gains compared with resistance exercise alone (Hickson 1980, Nader 2006) − a 3 
phenomenon known as concurrent training or interference effect. Similarly, when endurance 4 
exercise is supplemented with resistance exercise in young male trained endurance athletes, 5 
typically no increase in muscle fiber CSA and leg lean mass is observed (Aagaard et al. 2011, 6 
Hickson et al. 1988). Here, we clearly showed that vibroX is capable of overcoming this 7 
interference effect. It further appears that muscle hypertrophy in the vibroX group was 8 
primarily driven by the increase in MyHC-1 fiber size, since we found a positive correlation 9 
between MyHC-1 fiber hypertrophy and the increase in thigh lean mass. This finding is not 10 
surprising, given the fact that MyHC-1 fiber proportion in the M. vastus lateralis of our 11 
participants was clearly dominant over MyHC-2 fiber proportions. Conversely, we did not 12 
expect that MyHC-1 fibers in trained endurance athletes would undergo further hypertrophy 13 
as a result of vibroX training, because these fibers are innervated by small motoneurons with 14 
low recruitment thresholds and thus, they are believed to be activated during endurance-type 15 
exercise. Remarkably, the advantage of the vibroX training group in relation to muscle fiber 16 
hypertrophy was achieved with a significant lower time under tension compared to the RT 17 
group. However, average time under tension per training session was, for both training 18 
groups, in the predetermined range of 60 to 100 s per set. Therefore, we assume that this 19 
difference in training volume had no effect on the outcome. The reduction in time under 20 
tension irrespective of the applied load was possibly due to the ischemic pain. 21 
 22 
The blunted hypertrophy in response to conventional RT with concurrent endurance exercise 23 
might potentially be explained by conditions causing significant cellular energy stress (such 24 
as may be the case during high-volume and/or high-intensity endurance exercise), which will 25 
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promote an increased activity of 5′-AMP activated protein kinase (AMPK). AMPK is a 1 
heterotrimeric serine/threonine kinase, composed of a catalytic subunit (α) and two regulatory 2 
subunits (β and γ) (Steinberg and Kemp 2009). It serves as an energy sensor and is activated 3 
by an elevation in the AMP/ATP ratio, i.e. enhanced binding of AMP to the γ subunit leads to 4 
an increase in the phosphorylation of the Thr172 residue on AMPK, and subsequently 5 
induces an increase in AMPK activity (Steinberg and Kemp 2009). It has been shown that 6 
activation of AMPK inhibits energy consuming anabolic processes such as protein synthesis, 7 
and stimulates catabolic energy producing processes such as protein degradation (Steinberg 8 
and Kemp 2009). Taken together, there is evidence suggesting that AMPK may negatively 9 
affect skeletal muscle mass accretion in the setting of concurrent training by blunting the 10 
increase in protein synthesis and increasing protein degradation (Goodman et al. 2011).  11 
 12 
Contrary to conventional RT, vibroX produced a robust hypertrophic response, which might 13 
theoretically either indicate that the addition of vibration and occlusion inhibited AMPK 14 
interference or that alternate pathways mediating muscle hypertrophy were activated. An 15 
inhibition of AMPK interference might represent a potential mechanism. However, we are 16 
not aware of any study investigating this potential mechanism. In contrast, we previously 17 
showed, using the same training protocols, that vibroX strongly induces peroxisome 18 
proliferator-activated receptor-γ coactivator 1α (PGC-1α) without concomitantly increasing 19 
the canonical PGC-1α downstream targets mediating mitochondrial biogenesis in 20 
recreationally trained men (Item et al. 2013). Interestingly, Ruas et al. (2012) have recently 21 
identified a form of PGC-1α (PGC-1α4) that results from alternative promoter usage and 22 
splicing of the primary transcript. Although it is highly expressed in exercised muscle, it does 23 
not regulate most known PGC-1α targets such as the mitochondrial OXPHOS genes. This is 24 
in principle consistent with our previous observation (Item et al. 2013). Ruas et al. (2012) 25 
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showed in vitro and in vivo that PGC-1α4 specifically induces insulin-like growth factor 1 1 
(IGF1) and represses myostatin in the context of resistance exercise, resulting in muscle 2 
hypertrophy. In the light of the findings that vibroX specifically and acutely increases PGC-3 
1α mRNA abundance and induces muscle hypertrophy despite concurrent endurance 4 
exercise, more research is needed to elucidate the possible roles of PGC-1α splice variants in 5 
mediating muscle size adaptation during vibroX. 6 !7 
As shown by linear regression analysis, we found a positive correlation between the increases 8 
in CP and capillarization after vibroX training. Notably, these increases occurred without 9 
concomitant elevations in V̇O2peak and/or skeletal muscle oxidative enzyme activities. These 10 
findings are in line with the notion that in endurance-trained muscles, the augmented 11 
capillarization serves other purposes than the oxygenation of tissue, namely a better uptake of 12 
substrates and/or removal of fatigue-related metabolites and heat (Saltin et al. 1986). 13 
Consequently, the enhanced CP observed following vibroX training may, in part, have been 14 
the result of better conditions for the uptake and utilization of blood-borne substrates and/or 15 
removal of fatigue-related metabolites. Interestingly, it also appears that the increased size of 16 
the capillary-to-fiber interface after vibroX was functionally (in terms of CP) more relevant 17 
than a decreased diffusion distance consequent to increased capillary density. The reason for 18 
this is that vibroX also induced myofiber hypertrophy. 19 
 20 
Recently, we showed in recreationally resistance trained young men that an acute bout of 21 
vibroX does not increase hypoxia-inducible factor-1α (HIF-1α) mRNA abundance nor the 22 
expression of HIF-1α target genes (e.g. HIFα prolyl hydroxylase domain 3 [PHD3], lactate 23 
dehydrogenase A [LDHA], or phosphofructokinase [PFK]), in spite of a marked increase in 24 
the expression of vascular endothelial growth factor (VEGF), PGC-1α, and oxidative stress 25 
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markers (Item et al. 2013). Given the known sensitivity of PGC-1α signaling to reactive 1 
oxygen species (Kang et al. 2009, St-Pierre et al. 2006), we speculate that VEGF expression 2 
was induced in a HIF-1 independent manner, possibly through oxidative stress dependent 3 
activation of PGC-1α. Our present finding that vibroX significantly increased capillarization 4 
in trained endurance athletes provides converging evidence that vibroX promotes 5 
capillarization through non-canonical signaling pathways. The reason being, that in trained 6 
endurance athletes most adaptations in terms of capillarization presumably have already 7 
occurred, and no further significant effects are to be expected by their classical training 8 
routine. Unlike vibroX, RT alone was unable to increase the capillary-to-fiber ratio in 9 
endurance-trained individuals participating in this study. This finding is in accordance with a 10 
recently published study by Aagaard et al. (2011), showing that capillary-to-fiber ratio did 11 
not increase following 16 weeks of endurance training supplemented with resistance exercise 12 
in elite cyclists. 13 
 14 
The increase in W′ was only statistically significant in the RT group and twofold greater than 15 
in the vibroX training group. This was surprising, because an increase in thigh lean mass, 16 
which is believed to influence W′ (Miura et al. 2002), was observed solely in the vibroX 17 
group. Furthermore, the share of MyHC-2A fibers, which is also believed to influence W′, 18 
increased in the vibroX training group and tended to increase in the RT group at the expense 19 
of MyHC-2X and MyHC-1 fibers, even though both decreases were not statistically 20 
significant. However, the increase in W′ in the RT group was paralleled by increases in MVT 21 
and RFD. Therefore, the augmentation in W′ was probably due to improved neuronal 22 
function. The discrepancy in adaptation between the two training groups might be explained 23 
by a ceiling effect. There is a balance between CP and W′, both parameters representing 24 
distinct parts of energy supply (oxidative and glycolytic, respectively).  In an individual 25 
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athlete, it is not possible to increase both parameters limitlessly (e.g. a marathon runner won’t 1 
achieve the same W′ as a 100 m sprinter and vice versa for CP). The idea of a ceiling effect 2 
might be supported by our findings that W′, MVT, and RFD at the beginning of the study 3 
tended to be lower in the RT group as compared to the vibroX group but were not different 4 
any more after the exercise period. The notion that a ceiling effect exists is further supported 5 
by the results of Bishop and Jenkins (1996). In their study, untrained males exhibit similar 6 
gains in 1RM, comparable to our RT group (+28.6% vs. +30.0%, respectively), but the 7 
magnitude of the increase in W′ was markedly higher (+34.9% vs. +6.5%, respectively). The 8 
above-mentioned slight increase in MyHC-2A fiber proportion might have benefited the 9 
overall outcome of the cycling tests, but presumably only to a small extent. This finding is in 10 
line with the results of Aagaard et al. (2011), who showed that even in elite competitive 11 
cyclists, proportional distribution of MyHC-2A increases after a RT intervention. Similar to 12 
the results of previous studies investigating the effects of additional RT in endurance-trained 13 
athletes (Aagaard et al. 2011, Hickson et al. 1988, Losnegard et al. 2011), RT alone 14 
increased 1RM, MVT, RFD and SJ relative maximum power in this study, demonstrating that 15 
our RT protocol was a valid and effective control condition. 16 
 17 
While we demonstrated that vibroX is a potent new training stimulus, we can only speculate 18 
about some of the mechanisms, which may mediate its effects. Specifically, the role and 19 
contribution of the single vibroX components are still unknown. On the one hand, the 20 
compressive cuff during vascular occlusion restricts arterial inflow, resulting in hypoxia and 21 
greater metabolic acidosis, while concomitantly blocking venous outflow resulting in 22 
continual stimulation of the afferents (Manini and Clark 2009). Blood flow restricted exercise 23 
thus may result in greater stimulation of chemosensitive sensory nerves arising from the 24 
active musculature (namely class III and IV afferents), which in turn result in an acute 25 
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increase in serum growth hormone and catecholamines. In addition, β-adrenergic receptor 1 
density is approximately threefold greater in type 1 than in type 2 fibers (Martin et al. 1989, 2 
Martin et al. 1992). Together with the possibility that β-adrenergic stimulation might induce a 3 
PGC-1α signaling (possibly through PGC-1α4) this might constitute a hypothetical 4 
mechanism, which could help to explain why type 1 fiber hypertrophy occurred during 5 
vibroX training. On the other hand, we speculate that the vibration-induced reflex activity 6 
was associated with the recruitment of distinct, task-related subpopulations of motor units 7 
(“functional motor unit pools”) (Burke 2002). There are indeed examples in which two or 8 
more functional motor unit pools share a single muscle compartment, and that the 9 
motoneurons of these functional pools are intermixed within the same spinal motor nucleus 10 
(Burke 2002). In theory, vibration-induced reflexes during vibroX could therefore lead to 11 
task-specific recruitment of additional motor units that otherwise are not recruited during 12 
squat exercise. It is clear, however, that adaptations to vibroX are significantly more (in terms 13 
of quantity and quality) than the sum of the adaptations usually observed for its single 14 
components, and these gains may be achieved with a minimal training time commitment. 15 
Moreover, given that vibroX produces universal (contrary to specific) effects, further 16 
research is warranted to elucidate the mechanisms underlying adaptations/effects and to 17 
establish optimal dose-response relationships. In addendum, we would like to point out that, 18 
until now, vibroX was only applied in healthy, untrained to trained participants and that the 19 
safety in other groups of participants, especially patients, has not been evaluated, yet. 20 
 21 
Conclusions 22 
In conclusion, this study has provided the final proof of concept that modification of 23 
resistance exercise by superimposing side-alternating whole body vibration and sustained 24 
vascular occlusion induced further improvements in CP, capillarization and hypertrophy in 25 
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trained endurance athletes, all of which had not been observed with RT alone. The increment 1 
in CP was positively correlated with the increase in overall capillary-to-fiber ratio. The gain 2 
in thigh lean mass was mainly due to MyHC-1 fiber hypertrophy. Increases in W′ and 3 
dynamometry parameters were only detected after RT, while both groups showed 4 
improvements in 1RM and maximum jumping power. On the basis of these findings, we 5 
recommend that trained endurance athletes who aim at further improving their endurance 6 
performance should consider vibroX as an additional new training modality.  7 
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Table 1. Physical characteristics and pre training values for 
the vibroX and resistance training (RT) groups.  
 
vibroX (n = 11) 
 
RT (n = 10) 
Age [y] 26.7 ± 3.5 
 
28.4 ± 4.8 
Height [cm] 181.5 ± 6.6 
 
178.8 ± 6.3 
Body mass [kg] 77.9 ± 8.1 
 
75.5 ± 7.0 
        CP [W] 286.4 ± 37.8 
 
274.3 ± 43.9 
CP·kg−1 [W·kg−1] 3.70 ± 0.53 
 
3.65 ± 0.62 
1RM [kg] 128.1 ± 20.2 
 
130.3 ± 39.2 
MVT [Nm] 169.4 ± 24.8 
 
166.5 ± 29.5 
RFD 30 ms [Nm·s−1] 1447.8 ± 526.5 
 
1272.8 ± 405.6 
RFD 200 ms [Nm·s−1] 1088.9 ± 280.0 
 
978.7 ± 280.1 
SJ Pmax,rel  [W·kg−1] 49.4 ± 4.0 
 
51.6 ± 6.0 
CMJ Pmax,rel  [W·kg−1] 55.2 ± 6.4 
 
60.2 ± 6.0 
        Overall CTF ratio 1.82 ± 0.20 
 
1.86 ± 0.19 
MyHC-1 fiber CSA [10−9 m2] 4.51 ± 0.66 
 
4.82 ± 1.16 
MyHC-2 fiber CSA [10−9 m2] 5.78 ± 0.67 
 
6.33 ± 1.03 
Thigh lean mass [kg] 13.6 ± 1.9   13.4 ± 1.2 
Values are mean ± SD: CP, critical power; 1RM, one-
repetition maximum; MVT, maximal voluntary torque; RFD, 
rate of force development; SJ, squat jump; CMJ, 
countermovement jump; Pmax,rel, relative maximal power; 
CTF, capillary-to-fiber; MyHC, myosin heavy chain; CSA, 
cross-sectional area. 
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Table 2. Distribution of the myosin heavy chain (MyHC) types, glycerol-3-phosphate 
dehydrogenase (GPDH) activity, and succinat dehydrogenase (SDH) activity pre and 
post training period in the vibroX and resistance training (RT) group. 
  vibroX (n = 9)   RT (n =10) 
  Pre Post   Pre Post 
MyHC-1 58.7% ± 6.7% 56.6% ± 7.0% 
 
59.2% ± 14.7% 56.1% ± 11.7% 
MyHC-2A 36.6% ± 8.6% 40.7% ± 5.6%* 37.3% ± 13.7% 42.3% ± 12.1%† 
MyHC-2X 4.7% ± 4.3% 2.7% ± 3.3% 
 
3.5% ± 3.1% 1.6% ± 1.7% 
              GPDH activity 47.9% ± 9.4% 50.3% ± 9.4% 
 
44.3% ± 13.4% 48.2% ± 12.3% 
              SDH high activity 60.9% ± 6.0% 60.9% ± 5.3% 
 
61.7% ± 7.1% 60.4% ± 8.3% 
SDH weak activity 38.5% ± 5.9% 38.2% ± 5.3% 
 
37.7% ± 7.1% 39.3% ± 8.5% 
SDH no activity 0.7% ± 1.1% 1.0% ± 2.2%   0.7% ± 0.9% 0.3% ± 0.5% 
Values are mean ± SD. *P < 0.05; †P = 0.051 pre vs. post. 
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Legends 1 
Figure 1: Study design on a weekly scale (−2 to 10). B, biopsy; C, constant-load tests; D, 2 
dual-energy x-ray absorptiometry; F, familiarization; I, incremental ramp test; R, testing of 3 
1RM, dynamometry and jumping mechanography; T1-16, training sessions. 4 
 5 
Figure 2: Critical Power (CP) pre (white bars) and post (black bars) training in the vibroX 6 
and resistance training group. Bars and error bars represent mean values and SD, 7 
respectively, for 21 participants (vibroX: n = 11, resistance n = 10). **P < 0.01, significant 8 
differences within group pre vs. post; #P < 0.05, significant differences between groups pre 9 
vs. post. 10 
 11 
Figure 3: a) Overall capillary-to-fiber ratio, b) thigh lean mass, c) myosin heavy chain type 1 12 
(MyHC-1) fiber cross-sectional area (CSA), and d) MyHC-2 fiber CSA pre (white bars) and 13 
post (black bars) training in the vibroX and resistance training group. Bars and error bars 14 
represent mean values and SD, respectively, for 21 (Fig. 3a, 3b; vibroX: n = 11, resistance n 15 
= 10) or 19 participants (Fig. 3c, 3d; vibroX: n = 9, resistance n = 10). *P < 0.05, **P < 0.01, 16 
significant differences within group pre vs. post; #P < 0.05, ##P < 0.01, significant differences 17 
between groups pre vs. post. 18 
 19 
Figure 4: a) One repetition maximum (1RM), b) maximum voluntary torque (MVT), c) squat 20 
jump (SJ) relative maximum power (Pmax,rel), d) countermovement jump (CMJ) relative 21 
maximum power (Pmax,rel), e) rate of force development (RFD) during the first 30ms of 22 
contraction, and f) RFD during the first 200ms of contraction pre (white bars) and post (black 23 
bars) training in the vibroX and resistance training group. Bars and error bars represent mean 24 
values and SD, respectively, for 21 participants (vibroX: n = 11, resistance n = 10). *P < 25 
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0.05, ***P < 0.001, significant differences within group pre vs. post. 1 
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